Cited by 268Gut microbiota and healthPharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics

Open access

Carmody, Rachel N., Turnbaugh, Peter J.·2014·Journal of Clinical Investigation

DOI 10.1172/jci72335PMC PMC4191041

Open this paper in CoChat — free account Open PDF

Abstract

Our associated microbial communities play a critical role in human health and predisposition to disease, but the degree to which they also shape therapeutic interventions is not well understood. Here, we integrate results from classic and current studies of the direct and indirect impacts of the gut microbiome on the metabolism of therapeutic drugs and diet-derived bioactive compounds. We pay particular attention to microbial influences on host responses to xenobiotics, adding to the growing consensus that treatment outcomes reflect our intimate partnership with the microbial world, and providing an initial framework from which to consider a more comprehensive view of pharmacology and nutrition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci72335

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Self-citation
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Casarett and Doull's Toxicology: The Basic Science of Poisons
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_2 · Cited by 3,304
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
Dethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050
Interaction between Phenolics and Gut Microbiota: Role in Human Health
Selma, M. V., Espín, J. C., & Tomás-Barberán, F. A. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902107d · Cited by 1,324
CALCIUM OXALATE IN PLANTS: Formation and Function
Franceschi, V. R., & Nakata, P. A. (2005) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.56.032604.144106 · Cited by 1,304
Casarett & Doull's Toxicology: The Basic Science of Poisons
Klaassen, C. D. (1998) · Cited by 1,179
Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism
Nicholson, J. K., & Wilson, I. D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1157 · Cited by 1,126
Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota
Hehemann, J.-H., Correc, G., Barbeyron, T., Helbert, W., Czjzek, M., & Michel, G. (2010) · Nature · doi:10.1038/nature08937 · Cited by 1,117
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Polycyclic aromatic hydrocarbons in the diet
Phillips, D. H. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5742(99)00016-2 · Cited by 856
Targeting gut microbiota in obesity: effects of prebiotics and probiotics
Delzenne, N. M., Neyrinck, A. M., Bäckhed, F., & Cani, P. D. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.126 · Cited by 805
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904489106 · Cited by 765
Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., & Turnbaugh, P. J. (2013) · Science · doi:10.1126/science.1235872 · Cited by 704 · cited 2×
“This “cardiac glycoside reductase” ( cgr ) operon is present in the type strain of E. lenta but missing in other nonreducing E. lenta strains (20).”
Self-citation
Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme
Craciun, S., & Balskus, E. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215689109 · Cited by 701
Interactions of gut microbiota with functional food components and nutraceuticals
Laparra, J. M., & Sanz, Y. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.001 · Cited by 684
Fecal microbiota transplantation and emerging applications
Borody, T. J., & Khoruts, A. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.244 · Cited by 677
Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish
Sügimura, T., Wakabayashi, K., Nakagama, H., & Nagao, M. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03205.x · Cited by 676
Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily
Watkins, P. B., Kaplowitz, N., Slattery, J. T., Colonese, C. R., Colucci, S. V., Stewart, P. W., & Harris, S. (2006) · JAMA · doi:10.1001/jama.296.1.87 · Cited by 631
The gastrointestinal microbiota as a site for the biotransformation of drugs
Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618
The Impact of a Consortium of Fermented Milk Strains on the Gut Microbiome of Gnotobiotic Mice and Monozygotic Twins
McNulty, N. P., Yatsunenko, T., Hsiao, A., Faith, J. J., Muegge, B. D., Goodman, A. L., Henrissat, B., Oozeer, R., Cools-Portier, S., Gobert, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002701 · Cited by 559
Predicting a Human Gut Microbiota’s Response to Diet in Gnotobiotic Mice
Faith, J. J., McNulty, N. P., Rey, F. E., & Gordon, J. I. (2011) · Science · doi:10.1126/science.1206025 · Cited by 536
Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.
Gupta, E., Lestingi, T. M., Mick, R., Ramirez, J., Vokes, E. E., & Ratain, M. J. (1994) · PubMed · Cited by 501
A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association
Cross, A. J., Ferrucci, L. M., Risch, A., Graubard, B. I., Ward, M. H., Park, Y., Hollenbeck, A. R., Schatzkin, A., & Sinha, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3929 · Cited by 469
THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE
PEPPERCORN, M. A., & GOLDMAN, P. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29238-2 · Cited by 450
Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy
Lindenbaum, J., Rund, D. G., Butler, V. P., Tse-Eng, D., & Saha, J. R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110013051403 · Cited by 423
Colonization-induced host-gut microbial metabolic interaction
Claus, S. P., Ellero, S. L., Berger, B., Krause, L., Bruttin, A., Molina, J., Paris, A., Want, E. J., de Waziers, I., Cloarec, O., et al. (2011) · mBio · doi:10.1128/mbio.00271-10 · Cited by 414
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.
Davies, G. R., Simmonds, N. J., Stevens, T., Sheaff, M., Banatvala, N., Laurenson, I. F., Blake, D. R., & Rampton, D. S. (1994) · Gut · doi:10.1136/gut.35.2.179 · Cited by 413
Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid
Couteau, D., McCartney, A. L., Gibson, G. R., Williamson, G., & Faulds, C. B. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2001.01316.x · Cited by 305
Digoxin-Inactivating Bacteria: Identification in Human Gut Flora
Dobkin, J. F., Saha, J. R., Butler, V. P., Neu, H. C., & Lindenbaum, J. (1983) · Science · doi:10.1126/science.6836275 · Cited by 259
Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes
Laine, J., Auriola, S. O. K., Pasanen, M., & Juvonen, R. O. (2009) · Xenobiotica · doi:10.1080/00498250802512830 · Cited by 258
Intestinal Microbiota Regulate Xenobiotic Metabolism in the Liver
Björkholm, B., Bok, C. M., Lundin, A., Rafter, J., Hibberd, M. L., & Pettersson, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006958 · Cited by 249
Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria
Orrhage, K., Sillerström, E., Gustafsson, J.-Å., Nord, C. E., & Rafter, J. J. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90182-1 · Cited by 234
Oxalate Degradation by Gastrointestinal Bacteria from Humans
Allison, M. J., Cook, H. M., MILNE, D. B., Gallagher, S. K., & Clayman, R. V. (1986) · Journal of Nutrition · doi:10.1093/jn/116.3.455 · Cited by 225
p‐Hydroxyphenylacetate decarboxylase from Clostridium difficile: A novel glycyl radical enzyme catalysing the formation of p‐cresol
Selmer, T., & Andrei, P. I. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02001.x · Cited by 214
Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1
Höppe, B., Beck, B. B., Gatter, N., von Unruh, G., Tischer, A., Hesse, A., Laube, N., Kaul, P., & Sidhu, H. (2006) · Kidney International · doi:10.1038/sj.ki.5001707 · Cited by 214
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., Bernardi, G., Bergamaschi, A., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000221672.01272.ba · Cited by 199
Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics
Haiser, H. J., Seim, K. L., Balskus, E. P., & Turnbaugh, P. J. (2014) · Gut Microbes · doi:10.4161/gmic.27915 · Cited by 197
Self-citation
Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice
LoGuidice, A., Wallace, B. D., Bendel, L., Redinbo, M. R., & Boelsterli, U. A. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.191122 · Cited by 197
Developing a metagenomic view of xenobiotic metabolism
Haiser, H. J., & Turnbaugh, P. J. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.07.009 · Cited by 186
Self-citation
Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humansPreprint
Harrill, A. H., Watkins, P. B., Su, S., Ross, P. K., Harbourt, D. E., Stylianou, I. M., Boorman, G. A., Russo, M. W., Sackler, R. S., Harris, C., et al. (2009) · Genome Research · doi:10.1101/gr.090241.108 · Cited by 177
Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients.
Kehrer, D. F. S., Sparreboom, A., Verweij, J., de Bruijn, P., Nierop, C. A., van de Schraaf, J., Ruijgrok, E. J., & de Jonge, M. J. (2001) · PubMed · Cited by 176
Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes
Saad, R., Rizkallah, M. R., & Aziz, R. K. (2012) · Gut Pathogens · doi:10.1186/1757-4749-4-16 · Cited by 167
Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics
Saitta, K. S., Zhang, C., Lee, K. K., Fujimoto, K., Redinbo, M. R., & Boelsterli, U. A. (2014) · Xenobiotica · doi:10.3109/00498254.2013.811314 · Cited by 165
Melamine-Induced Renal Toxicity Is Mediated by the Gut Microbiota
Zheng, X., Zhao, A., Xie, G., Chi, Y., Zhao, L., Li, H., Wang, C., Bao, Y., Jia, W., Luther, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005114 · Cited by 155
Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers
Hamlet, A., Thoreson, A.-C. E., Nilsson, O., Svennerholm, A., & Olbe, L. C. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70121-6 · Cited by 153
Disorders of oxalate metabolism
Williams, H. E., & Smith, L. H. (1968) · The American Journal of Medicine · doi:10.1016/0002-9343(68)90207-6 · Cited by 151
Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization withOxalobacter
Hatch, M., Gjymishka, A., SALIDO, E. C., Allison, M. J., & Freel, R. W. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00434.2010 · Cited by 147
Oxalobacter formigenes and its role in oxalate metabolism in the human gut
Stewart, C. S., Duncan, S. H., & Cave, D. R. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00864-4 · Cited by 146
Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines
Knasmüller, S., Steinkellner, H., Hirschl, A. M., Rabot, S., Nobis, E., & Kassie, F. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00176-2 · Cited by 142
Detection of ferulic acid esterase production by Bacillus spp. and lactobacilli
Donaghy, J., Kelly, P. F., & McKay, A. M. (1998) · Applied Microbiology and Biotechnology · doi:10.1007/s002530051286 · Cited by 141
Selective in vitro binding of dietary mutagens, individually or in combination, by lactic acid bacteria
Turbić, A., Ahokas, J. T., & Haskard, C. A. (2002) · Food Additives & Contaminants · doi:10.1080/02652030110070067 · Cited by 139
Heterocyclic aromatic amine intake increases colorectal adenoma risk: findings from a prospective European cohort study
Rohrmann, S., Hermann, S., & Linseisen, J. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26658 · Cited by 127
In Vitro Binding of Potent Mutagenic Pyrolyzates to Intestinal Bacteria
Morotomi, M., & Mutal, M. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/77.1.195 · Cited by 123
Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil
Nakayama, H., Kinouchi, T., Kataoka, K., Akimoto, S., Matsuda, Y., & Ohnishi, Y. (1997) · Pharmacogenetics · doi:10.1097/00008571-199702000-00005 · Cited by 120
Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats
Takasuna, K., Hagiwara, T., Hirohashi, M., Kato, M., Nomura, M., Nagai, E., Yokoi, T., & Kamataki, T. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050818 · Cited by 120
Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
Okuda, H., Nishiyama, T., Ogura, K., Nagayama, S., Ikeda, K., Yamaguchi, S., Nakamura, Y., KAWAGUCHI, Y., Watabe, T., & Ogura, Y. (1997) · PubMed · Cited by 106
Intestinal flora induces the expression of Cyp3a in the mouse liver
Toda, T., Saito, N., Ikarashi, N., Ito, K., Yamamoto, M., ISHIGE, A., Watanabe, K., & Sugiyama, K. (2009) · Xenobiotica · doi:10.1080/00498250802651984 · Cited by 102
The Metabolic and Ecological Interactions of Oxalate-Degrading Bacteria in the Mammalian Gut
Miller, A., & Dearing, D. (2013) · Pathogens · doi:10.3390/pathogens2040636 · Cited by 101
The Role of Intestinal Microbiota in Development of Irinotecan Toxicity and in Toxicity Reduction through Dietary Fibres in Rats
Lin, X. B., Farhangfar, A., Valcheva, R. S., Sawyer, M. B., Dieleman, L. A., Schieber, A., Gänzle, M. G., & Baracos, V. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083644 · Cited by 99
-Glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in rats
Humblot, C., Murkovic, M., Rigottier-Gois, L., Bensaada, M., Bouclet, A., Andrieux, C., Anba, J., & Rabot, S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm170 · Cited by 98
THE ASSOCIATION OF GASTRO‐DUODENAL ULCERATION AND PARKINSON'S DISEASE
Strang, R. R. (1965) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1965.tb72277.x · Cited by 95
Metabonomic Evaluation of Melamine-Induced Acute Renal Toxicity in Rats
Xie, G., Zheng, X., Qi, X., Cao, Y., Chi, Y., Su, M., Ni, Y., Qiu, Y., Liu, Y., Li, H., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr900333h · Cited by 94
CONTRIBUTIONS OF HOST AND INTESTINAL MICROFLORA IN THE METABOLISM OF l-DOPA BY THE RAT
Goldin, B. R., Peppercorn, M. A., & Goldman, P. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29577-5 · Cited by 91
Role of Intestinal Microorganisms in Determining Cycasin Toxicity
Spatz, M., Smith, D. W., McDaniel, E. G., & Laqueur, G. L. (1967) · Experimental Biology and Medicine · doi:10.3181/00379727-124-31826 · Cited by 88
The mechanism of renal stone formation and renal failure induced by administration of melamine and cyanuric acid
Kobayashi, T., Okada, A., Fujii, Y., Niimi, K., Hamamoto, S., Yasui, T., Tozawa, K., & Kohri, K. (2010) · Urological Research · doi:10.1007/s00240-010-0254-9 · Cited by 84
Fungal transformation of ferulic acid from sugar beet pulp to natural vanillin
Lesage‐Meessen, L., Stentelaire, C., Lomascolo, A., Couteau, D., Asther, M., Moukha, S., Record, É., Sigoillot, J., & Asther, M. (1999) · Journal of the Science of Food and Agriculture · doi:10.1002/(sici)1097-0010(19990301)79:3 · Cited by 83
Glucuronidation of N -hydroxy heterocyclic amines by human and rat liver microsomes
Kaderlik, K. R., Mulder, G. J., Turesky, R. J., Lang, N. P., Teitel, C. H., Chiarelli, M. P., & Kadlubar, F. F. (1994) · Carcinogenesis · doi:10.1093/carcin/15.8.1695 · Cited by 82
In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?
Niehues, M., & Hensel, A. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.10.0005 · Cited by 79
Improved stability and release control of levodopa and metaraminol using ion-exchange fibers and transdermal iontophoresis
Kankkunen, T., Huupponen, I., Lahtinen, K., Sundell, M. J., Ekman, K. B., Kontturi, K., & Hirvonen, J. J. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00113-6 · Cited by 70
Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)
Kassie, F. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1721 · Cited by 70
Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains
Zsivkovits, M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg167 · Cited by 68
Caffeic Acid Metabolism by Gnotobiotic Rats and Their Intestinal Bacteria
Peppercorn, M. A., & Goldman, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1413 · Cited by 67
InVivo Release of 14C-Labelled Phenolic Groups from Intact Dietary Spinach Cell Walls During Passage Through the Rat Intestine
Buchanan, C. J., Wallace, G., Fry, S. C., & Eastwood, M. A. (1996) · Journal of the Science of Food and Agriculture · doi:10.1002/(sici)1097-0010(199608)71:4 · Cited by 65
Identification of an Enzyme System for Daidzein-to-Equol Conversion in Slackia sp. Strain NATTS
Tsuji, H., Moriyama, K., Nomoto, K., & Akaza, H. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.06779-11 · Cited by 64
Levodopa delivery systems for the treatment of Parkinson's disease: An overview
Goole, J., & Amighi, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.026 · Cited by 51
Effects of human intestinal flora on mutagenicity of and DNA adduct formation from food and environmental mutagens
Hirayama, K. (2000) · Carcinogenesis · doi:10.1093/carcin/21.11.2105 · Cited by 51
Diagnosis and treatment of melamine-associated urinary calculus complicated with acute renal failure in infants and young children
Sun, N., Ying, S. H. E. N., Sun, Q., Li, X., Jia, L., ZHANG, G.-J., Zhang, W., Chen, Z., Fan, J., Jiang, Y., et al. (2009) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2009.03.002 · Cited by 51
Oxalate Toxicosis
James, L. F. (1972) · Clinical Toxicology · doi:10.3109/15563657208991002 · Cited by 51
TLR2 Controls Intestinal Carcinogen Detoxication by CYP1A1
Do, K. N., Fink, L. N., Jensen, T. E., Gautier, L., & Parlesak, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032309 · Cited by 48
Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation
Rodby, R. A., Tyszka, T. S., & Williams, J. W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80091-y · Cited by 43
Characterization of melamine-associated urinary stones in children with consumption of melamine-contaminated infant formula
Chang, H., Shi, X., Shen, W., Wang, W., & Yue, Z. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.02.025 · Cited by 29
CANCER CHEMOTH PHARM
阮懷磊, 楊志仁, 尹莘玲, 王東衡, 黃吉志, 黃明賢, Juan, H.-L., Yang, C., Yin, H., Wang, T., et al. (2014) · Cited by 10

Flagged first, then by citations

Research works printed but not linked: 6

Finkel R, Cubeddu LX, Clark MA. Pharmacology. 4th ed. Baltimore, Maryland, USA: Lippincott Williams & Wilkins; 2009.
Morotomi, 1986, J Natl Cancer Inst., 77, 195
Gupta, 1994, Cancer Res., 54, 3723
Kehrer, 2001, Clin Cancer Res., 7, 1136
Zheng, 2013, Sci Transl Med., 5, 172ra122
Okuda, 1997, Drug Metab Dispos., 25, 270

Sorted by citations

Cancer and the microbiota
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Microbiota: a key orchestrator of cancer therapy
Roy, S., & Trinchieri, G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.13 · Cited by 883
Mining the Human Gut Microbiota for Immunomodulatory Organisms
Geva-Zatorsky, N., Sefik, E., Kua, L., Pasman, L., Tan, T. G., Ortiz-Lopez, A., Yanortsang, T. B., Yang, L., Jupp, R., Mathis, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.01.022 · Cited by 762
“Cytochrome p450 controls mechanisms of xenobiotic metabolism in the gut (Carmody and Turnbaugh, 2014) and, together with other members of this cluster (e.g., Rdh7 or Aldh1), influences the metabolism of all trans-retinoic acid.”
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
Spanogiannopoulos, P., Bess, E. N., Carmody, R. N., & Turnbaugh, P. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.17 · Cited by 717
Self-citation

See all 268

Authors: Carmody, R. N., & Turnbaugh, P. J.
Corresponding author: Turnbaugh, Peter J.
ORCID: Carmody, Rachel N.
Turnbaugh, Peter J.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2014-08-08
Volume: 124
Issue: 10
Pages: 4173-4181
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci72335
PMC: PMC4191041
OpenAlex: W1964115194
Cited by: 268
References: 91
Citations by year: 2026: 17 · 2025: 16 · 2024: 10 · 2023: 15 · 2022: 23 · 2021: 47 · 2020: 33 · 2019: 26 · 2018: 21 · 2017: 19 · 2016: 23 · 2015: 14 · 2014: 3
FWCI: 1.85
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: Harvard University
National Institutes of Health
FAS Center for Systems Biology, Harvard University
National Institute of General Medical Sciences (P50GM068763)
National Institute of Diabetes and Digestive and Kidney Diseases (F32DK101154)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: host-microbe interactions, gut microbiota, xenobiotic metabolism, drug metabolism, therapeutic drugs, personalized medicine
MeSH terms: Animals, Binding Sites, Diet, Humans, Intestines, Mice, Transgenic, Protein Binding, Xenobiotics, Gene Expression Regulation, Bacterial, Probiotics, Gastrointestinal Tract, Mice, Microbial Interactions, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks